Brevan Howard Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,194
Closed -$805K 2346
2025
Q4
$805K Buy
10,194
+4,446
+77% +$352K 0.01% 872
2025
Q3
$473K Sell
5,748
-96,980
-94% -$7.63M ﹤0.01% 1321
2025
Q2
$8.26M Buy
102,728
+87,922
+594% +$6.78M 0.05% 230
2025
Q1
$1.19M Buy
14,806
+9,435
+176% +$785K 0.01% 436
2024
Q4
$440K Sell
5,371
-9,253
-63% -$770K ﹤0.01% 657
2024
Q3
$1.21M Sell
14,624
-17,022
-54% -$1.27M 0.01% 393
2024
Q2
$2.22M Buy
+31,646
New +$2.26M 0.02% 194
2024
Q1
Sell
-5,931
Closed -$392K 1216
2023
Q4
$392K Buy
+5,931
New +$371K ﹤0.01% 598

Other funds holding MET

Brevan Howard Capital Management's MET Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of MetLife (MET) in Q1 2026, closing a stake of 10,194 shares — an estimated $805K sold.

Brevan Howard Capital Management first reported a position in MET in Q4 2023 and held it in 8 quarters. The position peaked at $8.26M in Q2 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 10,194 MetLife shares in Q1 2026, an estimated $805K.
  • Brevan Howard Capital Management first reported a position in MetLife in Q4 2023 and held it in 8 quarters.
  • Brevan Howard Capital Management's MetLife position peaked at $8.26M in Q2 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.